Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial
Conclusions
Intraperitoneal administration of PTX from the day of gastrectomy did not result in a higher incidence of surgical complications and adverse reactions when compared with intravenous administration of PTX.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research
More News: Anaphylactic Shock | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Gastrectomy | Gastric (Stomach) Cancer | Gastroenterology | Ovarian Cancer | Ovaries | Peritoneal Cancer | Pulmonary Thromboembolism | Study | Thrombosis